2,985 hedge funds and large institutions have $100B invested in Pfizer in 2024 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 933 increasing their positions, 1,460 reducing their positions, and 245 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

8% less capital invested

Capital invested by funds: $109B → $100B (-$8.71B)

15% less call options, than puts

Call options by funds: $3.28B | Put options by funds: $3.87B

36% less repeat investments, than reductions

Existing positions increased: 933 | Existing positions reduced: 1,460

Holders
2,985
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
42
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.28B
Puts
$3.87B
Net Calls
Net Calls Change

Top Sellers

1 -$644M
2 -$337M
3 -$293M
4
JP Morgan Chase
JP Morgan Chase
New York
-$285M
5
Barclays
Barclays
United Kingdom
-$277M
Name Holding Trade Value Shares
Change
Change in
Stake
926
$2.52M
927
$2.52M
928
$2.52M
929
$2.51M
930
$2.51M
931
$2.5M
932
$2.49M
933
$2.48M
934
$2.48M
935
$2.47M
936
$2.46M
937
$2.45M
938
$2.45M
939
$2.44M
940
$2.44M
941
$2.44M
942
$2.43M
943
$2.43M
944
$2.42M
945
$2.4M
946
$2.4M
947
$2.4M
948
$2.39M
949
$2.39M
950
$2.39M